Chinese English Japanese Germany Korea
ChemicalBook >제품 카탈로그 >3,7-디아자비시클로[3.3.0]옥탄

3,7-디아자비시클로[3.3.0]옥탄

3,7-디아자비시클로[3.3.0]옥탄
3,7-디아자비시클로[3.3.0]옥탄 구조식 이미지
카스 번호:
5840-00-6
한글명:
3,7-디아자비시클로[3.3.0]옥탄
동의어(한글):
3,7-디아자비시클로[3.3.0]옥탄
상품명:
3,7-Diazabicyclo[3.3.0]octane
동의어(영문):
3,7-Diazabicyclo[3.3.0]octane;Octahydropyrrolo[3,4-r]pyrrole;hexahydro-pyrrolo[3,4-c]pyrrole;3,7-DIAZABICYCLO[3.3.0]OCTANE,98%;Pyrrolo[3,4-c]pyrrole, octahydro-;1,2,3,3a,4,5,6,6a-octahydropyrrolo[3,4-c]pyrrole
CBNumber:
CB61493612
분자식:
C6H12N2
포뮬러 무게:
112.17
MOL 파일:
5840-00-6.mol

3,7-디아자비시클로[3.3.0]옥탄 속성

끓는 점
194 °C
밀도
0.975
인화점
90 °C
저장 조건
under inert gas (nitrogen or Argon) at 2–8 °C
산도 계수 (pKa)
11.23±0.20(Predicted)
안전
  • 위험 및 안전 성명
  • 위험 및 사전주의 사항 (GHS)
HS 번호 2921309990
그림문자(GHS): GHS hazard pictograms
신호 어: Warning
유해·위험 문구:
암호 유해·위험 문구 위험 등급 범주 신호 어 그림 문자 P- 코드
H302 삼키면 유해함 급성 독성 물질 - 경구 구분 4 경고 GHS hazard pictograms P264, P270, P301+P312, P330, P501
H315 피부에 자극을 일으킴 피부부식성 또는 자극성물질 구분 2 경고 GHS hazard pictograms P264, P280, P302+P352, P321,P332+P313, P362
H319 눈에 심한 자극을 일으킴 심한 눈 손상 또는 자극성 물질 구분 2A 경고 GHS hazard pictograms P264, P280, P305+P351+P338,P337+P313P
H335 호흡 자극성을 일으킬 수 있음 특정 표적장기 독성 - 1회 노출;호흡기계 자극 구분 3 경고 GHS hazard pictograms
예방조치문구:
P261 분진·흄·가스·미스트·증기·...·스프레이의 흡입을 피하시오.
P305+P351+P338 눈에 묻으면 몇 분간 물로 조심해서 씻으시오. 가능하면 콘택트렌즈를 제거하시오. 계속 씻으시오.

3,7-디아자비시클로[3.3.0]옥탄 C화학적 특성, 용도, 생산

3,7-디아자비시클로[3.3.0]옥탄 준비 용품 및 원자재

원자재

준비 용품

3,7-디아자비시클로[3.3.0]옥탄 공급 업체

글로벌( 53)공급 업체
공급자 전화 이메일 국가 제품 수 이점
CONIER CHEM AND PHARMA LIMITED 		+8618523575427
 sales@conier.com China 49392 58
career henan chemical co 		+86-0371-86658258 +8613203830695
 factory@coreychem.com China 29825 58
Guangzhou Yuheng Pharmaceutical Technology Co., Ltd 		+8613580539051
 joe@yuhengpharm.com CHINA 21149 58
Win-Win chemical CO., Limited 		+86-0086-577-64498589 +86-15355981851
 sales@win-winchemical.com China 14351 58
Dayang Chem (Hangzhou) Co.,Ltd. 		571-88938639 +8617705817739
 info@dycnchem.com China 52861 58
Nextpeptide Inc 		+86-0571-81612335 +8613336028439
 sales@nextpeptide.com China 19915 58
Nanjing Doge Biomedical Technology Co., Ltd 		+86-25-58227606 +86-15305155328
 sales@dogechemical.com China 4128 58
PT CHEM GROUP LIMITED
peter68@ptchemgroup.com China 35426 58
GIHI CHEMICALS CO.,LIMITED 		+8618058761490
 info@gihichemicals.com China 50000 58
LEAPCHEM CO., LTD. 		+86-852-30606658
market18@leapchem.com China 43348 58

3,7-디아자비시클로[3.3.0]옥탄 관련 검색:

노르말옥탄 1,8-디아자비사이클로[5.4.0]운덴센-7 피롤 3,7-Diazabicyclo[3.3.0]Octane dihydrochloride 3,7-Diazabicyclo[3.3.0]octane 5-(4-CHLOROPHENYL)-3-(1,3-DIOXO-1,3-DIHYDRO-2H-INDEN-2-YLIDEN)-4,6-DIOXOOCTAHYDROPYRROLO[3,4-C]PYRROLE-1-CARBOXYLIC ACID 4-(1,3-DIOXO-1,3-DIHYDRO-2H-INDEN-2-YLIDEN)-2-PHENYL-6-(2-PYRIDINYL)TETRAHYDROPYRROLO[3,4-C]PYRROLE-1,3(2H,3AH)-DIONE 2-(2,4-DICHLOROPHENYL)-4-(1,3-DIOXO-1,3-DIHYDRO-2H-INDEN-2-YLIDEN)-6-(2-PYRIDINYL)TETRAHYDROPYRROLO[3,4-C]PYRROLE-1,3(2H,3AH)-DIONE METHYL 1,5-DIBENZYL-3-(4-CHLOROPHENYL)-4,6-DIOXOOCTAHYDROPYRROLO[3,4-C]PYRROLE-1-CARBOXYLATE METHYL 3-(3-CHLOROPHENYL)-5-(4-CHLOROPHENYL)-4,6-DIOXO-1-PHENYLOCTAHYDROPYRROLO[3,4-C]PYRROLE-1-CARBOXYLATE METHYL 3-[4-(1,3-DIOXO-1,3-DIHYDRO-2H-INDEN-2-YLIDEN)-1,3-DIOXO-6-(2-PYRIDINYL)HEXAHYDROPYRROLO[3,4-C]PYRROL-2(1H)-YL]-2-THIOPHENECARBOXYLATE 2-(2-([3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]AMINO)ETHYL)-4-(1,3-DIOXO-1,3-DIHYDRO-2H-INDEN-2-YLIDEN)-6-(2-PYRIDINYL)TETRAHYDROPYRROLO[3,4-C]PYRROLE-1,3(2H,3AH)-DIONE METHYL 5-(4-CHLOROPHENYL)-4,6-DIOXO-1,3-DIPHENYLOCTAHYDROPYRROLO[3,4-C]PYRROLE-1-CARBOXYLATE 3-(1,3-DIOXO-1,3-DIHYDRO-2H-INDEN-2-YLIDEN)-4,6-DIOXO-5-[3-(TRIFLUOROMETHYL)PHENYL]OCTAHYDROPYRROLO[3,4-C]PYRROLE-1-CARBOXYLIC ACID METHYL 1-BENZYL-5-[2-(METHOXYCARBONYL)PHENYL]-3-(4-METHOXYPHENYL)-4,6-DIOXOOCTAHYDROPYRROLO[3,4-C]PYRROLE-1-CARBOXYLATE METHYL 1,5-DIBENZYL-3-(3-CHLOROPHENYL)-4,6-DIOXOOCTAHYDROPYRROLO[3,4-C]PYRROLE-1-CARBOXYLATE METHYL 1-BENZYL-3-(4-METHOXYPHENYL)-4,6-DIOXO-5-PHENYLOCTAHYDROPYRROLO[3,4-C]PYRROLE-1-CARBOXYLATE METHYL 1,5-DIBENZYL-3-(2-CHLOROPHENYL)-4,6-DIOXOOCTAHYDROPYRROLO[3,4-C]PYRROLE-1-CARBOXYLATE
Copyright 2019 © ChemicalBook. All rights reserved